首页> 外文期刊>Acta crystallographica. Section D, Structural biology >Crystal structure of a covalently linked Aurora-A-MYCN complex
【24h】

Crystal structure of a covalently linked Aurora-A-MYCN complex

机译:共价连接的Aurora-A-MYCN复合物的晶体结构

获取原文
获取原文并翻译 | 示例
           

摘要

Formation of the Aurora-A-MYCN complex increases levels of the oncogenic transcription factor MYCN in neuroblastoma cells by abrogating its degradation through the ubiquitin proteasome system. While some small-molecule inhibitors of Aurora-A were shown to destabilize MYCN, clinical trials have not been satisfactory to date. MYCN itself is considered to be `undruggable' due to its large intrinsically disordered regions. Targeting the Aurora-A-MYCN complex rather than Aurora-A or MYCN alone will open new possibilities for drug development and screening campaigns. To overcome the challenges that a ternary system composed of Aurora-A, MYCN and a small molecule entails, a covalently cross-linked construct of the Aurora-A-MYCN complex was designed, expressed and characterized, thus enabling screening and design campaigns to identify selective binders.
机译:形成Aurora-A-MYCN复杂的增加MYCN转录水平的致癌因素在神经母细胞瘤细胞通过废除它通过泛素蛋白酶体降解系统。Aurora-A被证明破坏MYCN,临床试验还没有令人满意的。本身被认为是无药可治”的原因其庞大的内在无序区域。而不是针对Aurora-A-MYCN复杂Aurora-A或独自MYCN将打开新的药物开发和筛选的可能性运动。组成的三元体系Aurora-A MYCN和小分子需要,一个共价交联Aurora-A-MYCN复杂的构造设计,表达和特征,从而使筛选和设计活动确定选择绑定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号